Cargando…

Two-Chains Tissue Plasminogen Activator Unifies Met and NMDA Receptor Signalling to Control Neuronal Survival

Tissue-type plasminogen activator (tPA) plays roles in the development and the plasticity of the nervous system. Here, we demonstrate in neurons, that by opposition to the single chain form (sc-tPA), the two-chains form of tPA (tc-tPA) activates the MET receptor, leading to the recruitment of N-Meth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hedou, Elodie, Douceau, Sara, Chevilley, Arnaud, Varangot, Alexandre, Thiebaut, Audrey M., Triniac, Hortense, Bardou, Isabelle, Ali, Carine, Maillasson, Mike, Crepaldi, Tiziana, Comoglio, Paolo, Lemarchand, Eloïse, Agin, Véronique, Roussel, Benoit D., Vivien, Denis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707453/ https://www.ncbi.nlm.nih.gov/pubmed/34948279 http://dx.doi.org/10.3390/ijms222413483

Ejemplares similares

MET Oncogene Controls Invasive Growth by Coupling with NMDA Receptor
por: Gallo, Simona, et al.
Publicado: (2022)

Impacts of tissue-type plasminogen activator (tPA) on neuronal survival
por: Chevilley, Arnaud, et al.
Publicado: (2015)

Tissue-type plasminogen activator controls neuronal death by raising surface dynamics of extrasynaptic NMDA receptors
por: Lesept, Flavie, et al.
Publicado: (2016)

Conformations of tissue plasminogen activator (tPA) orchestrate neuronal survival by a crosstalk between EGFR and NMDAR
por: Bertrand, T, et al.
Publicado: (2015)

Parvalbumin interneuron-derived tissue-type plasminogen activator shapes perineuronal net structure
por: Lépine, Matthieu, et al.
Publicado: (2022)

HGF and MET: From Brain Development to Neurological Disorders
por: Desole, Claudia, et al.
Publicado: (2021)

Proteostasis During Cerebral Ischemia
por: Thiebaut, Audrey M., et al.
Publicado: (2019)

Post-synaptic Release of the Neuronal Tissue-Type Plasminogen Activator (tPA)
por: Lenoir, Sophie, et al.
Publicado: (2019)

Modulations of the neuronal trafficking of tissue-type plasminogen activator (tPA) influences glutamate release
por: Varangot, Alexandre, et al.
Publicado: (2023)

Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagy
por: Gallo, S, et al.
Publicado: (2014)

Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody
por: Modica, Chiara, et al.
Publicado: (2020)

Blood tissue Plasminogen Activator (tPA) of liver origin contributes to neurovascular coupling involving brain endothelial N-Methyl-D-Aspartate (NMDA) receptors
por: Furon, Jonathane, et al.
Publicado: (2023)

Astrocytes regulate the balance between plasminogen activation and plasmin clearance via cell-surface actin
por: Briens, Aurélien, et al.
Publicado: (2017)

NMDA Receptor and Its Emerging Role in Cancer
por: Gallo, Simona, et al.
Publicado: (2023)

Activation of the MET receptor attenuates doxorubicin‐induced cardiotoxicity in vivo and in vitro
por: Gallo, Simona, et al.
Publicado: (2020)

An Observatory for the MET Oncogene: A Guide for Targeted Therapies
por: Altintas, Dogus M., et al.
Publicado: (2023)

Plasminogen Activator Inhibitor-1 (PAI-1) deficiency predisposes to depression and resistance to treatments
por: Party, Hélène, et al.
Publicado: (2019)

Tissue plasminogen activator inhibits NMDA-receptor-mediated increases in calcium levels in cultured hippocampal neurons
por: Robinson, Samuel D., et al.
Publicado: (2015)

HGF/Met Axis in Heart Function and Cardioprotection
por: Gallo, Simona, et al.
Publicado: (2014)

The Met oncogene and basal-like breast cancer: another culprit to watch out for?
por: Gastaldi, Stefania, et al.
Publicado: (2010)

ROR1 is a pseudokinase that is crucial for MET-driven tumorigenesis
por: Lazzari, Luca, et al.
Publicado: (2013)

Reviving oncogenic addiction to MET bypassed by BRAF (G469A) mutation
por: Virzì, Anna Rita, et al.
Publicado: (2018)

Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours
por: Martin, Valentina, et al.
Publicado: (2019)

MET Activation and Physical Dynamics of the Metastatic Process: The Paradigm of Cancers of Unknown Primary Origin
por: Stella, Giulia M., et al.
Publicado: (2017)

The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor Precursor
por: Altintas, Dogus Murat, et al.
Publicado: (2022)

A receptor-antibody hybrid hampering MET-driven metastatic spread
por: Modica, Chiara, et al.
Publicado: (2021)

Tissue plasminogen activator prevents white matter damage following stroke
por: Correa, Fernando, et al.
Publicado: (2011)

Core cysteine residues in the Plasminogen-Apple-Nematode (PAN) domain are critical for HGF/c-MET signaling
por: Pal, Debjani, et al.
Publicado: (2022)

Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy
por: Chiriaco, Cristina, et al.
Publicado: (2022)

Tissue plasminogen activator worsens experimental autoimmune encephalomyelitis by complementary actions on lymphoid and myeloid cell responses
por: Hélie, Pauline, et al.
Publicado: (2021)

The choroid plexus: a door between the blood and the brain for tissue-type plasminogen activator
por: Zuba, Vincent, et al.
Publicado: (2022)

hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of ‘MET-addicted’ cancers
por: Martinelli, Ilaria, et al.
Publicado: (2022)

ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy
por: Gallo, Simona, et al.
Publicado: (2019)

A High Affinity Hepatocyte Growth Factor-binding Site in the Immunoglobulin-like Region of Met
por: Basilico, Cristina, et al.
Publicado: (2008)

Correction: hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of ‘MET-addicted’ cancers
por: Martinelli, Ilaria, et al.
Publicado: (2022)

Correction to: The choroid plexus: A door between the blood and the brain for tissue-type plasminogen activator
por: Zuba, Vincent, et al.
Publicado: (2022)

MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk
por: Modica, Chiara, et al.
Publicado: (2018)

Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes
por: Sala, Valentina, et al.
Publicado: (2015)

Ezrin Is an Effector of Hepatocyte Growth Factor–mediated Migration and Morphogenesis in Epithelial Cells
por: Crepaldi, Tiziana, et al.
Publicado: (1997)

Roles of the tissue-type plasminogen activator in immune response
por: Seillier, Célia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p2ppaumhb9ml857kc9rg08p2ak